Description

BSE lists 2000 units of Commercial Paper issued by Nuvama Wealth and Investment Limited with face value of Rs. 5 lakhs each, maturing on 18 May 2026.

Summary

BSE has listed Commercial Paper issued by Nuvama Wealth and Investment Limited on private placement basis, effective from 29 October 2025. The instrument consists of 2000 units with a face value of Rs. 5,00,000 each, issued at a discount and maturing in approximately 6.5 months.

Key Points

  • Issuer: Nuvama Wealth and Investment Limited
  • Securities Type: Commercial Paper (privately placed)
  • Quantity: 2000 units
  • Face Value: Rs. 5,00,000 per unit
  • Issue Price: Rs. 4,79,182.50 per unit (discount of Rs. 20,817.50)
  • Scrip Code: 730447
  • Scrip ID: NWIL281025
  • Detail Name: NWIL-18-5-26-CP
  • ISIN: INE523L14AP1
  • Credit Rating: CRISIL A1+, ICRA A1+
  • Market Lot: 1 unit
  • Issuing and Paying Agent: ICICI Bank Ltd
  • Trading: Dematerialized form only, standard denomination of Rs. 5 lakhs and multiples thereof
  • Tick Size: 1 paise

Regulatory Changes

No regulatory changes introduced. This is a standard listing notification for new debt securities.

Compliance Requirements

  • Trading members must trade these securities only in dematerialized form under ISIN INE523L14AP1
  • Trading shall be conducted in standard denomination of Rs. 5 lakhs and multiples thereof
  • Members requiring clarification should contact the debt department at BSE on 22728352/8597/8995/5753/8915

Important Dates

  • Allotment Date: 28 October 2025
  • Listing Date: 29 October 2025
  • Redemption Date: 18 May 2026

Impact Assessment

This is a routine commercial paper listing with minimal market impact. The instrument provides short-term funding for Nuvama Wealth and Investment Limited and offers a debt investment option for institutional investors. The high credit ratings (CRISIL A1+ and ICRA A1+) indicate strong creditworthiness. Trading is restricted to the BSE Debt segment with no impact on equity markets or broader trading operations.

Impact Justification

Routine commercial paper listing with no market-wide implications; affects only debt segment trading members and investors in Nuvama's commercial paper.